IL-1α-activated PSC can assist cancer cell migration, which is known to be inhibited by TGF-β via blocking IL-1α-mediated secretion of hepatocyte growth factor and reducing IL-1 receptor expression (Tjomsland et al., 2016a). This evidence concerns the gene TGFB1 and cancer.